Literature DB >> 11273773

Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.

A Pfeifer1, T Kessler, M Yang, E Baranov, N Kootstra, D A Cheresh, R M Hoffman, I M Verma.   

Abstract

Viral vectors based on lentiviruses, such as the human immunodeficiency virus, are able to transduce a broad spectrum of nondividing cells in vivo. This ability of lentiviral vectors makes them an attractive vehicle for gene transfer into the liver. In order to determine the requirements for efficient lentiviral gene transfer, we used a fluorescence imaging system, which allows the detection of cells and tissues that express fluorescent reporter genes (e.g., green fluorescence protein) in the living animal. We show that the latest generation of lentiviral vectors efficiently transduces the murine liver. Further analysis demonstrated that neither cell-cycle activation nor division of liver cells is a prerequisite for lentiviral gene transfer in vivo.

Entities:  

Mesh:

Year:  2001        PMID: 11273773     DOI: 10.1006/mthe.2001.0276

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  23 in total

1.  Efficient transgenesis in farm animals by lentiviral vectors.

Authors:  Andreas Hofmann; Barbara Kessler; Sonja Ewerling; Myriam Weppert; Barbara Vogg; Harald Ludwig; Miodrag Stojkovic; Marc Boelhauve; Gottfried Brem; Eckhard Wolf; Alexander Pfeifer
Journal:  EMBO Rep       Date:  2003-10-17       Impact factor: 8.807

2.  Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector.

Authors:  Federico Mingozzi; Jörg Schüttrumpf; Valder R Arruda; Yuhong Liu; Yi-Lin Liu; Katherine A High; Weidong Xiao; Roland W Herzog
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Authors:  Ning Chai; Ho Eun Chang; Emmanuelle Nicolas; Severin Gudima; Jinhong Chang; John Taylor
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

4.  Volumetric tomography of fluorescent proteins through small animals in vivo.

Authors:  Giannis Zacharakis; Hirokazu Kambara; Helen Shih; Jorge Ripoll; Jan Grimm; Yoshinaga Saeki; Ralph Weissleder; Vasilis Ntziachristos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

5.  Targeted delivery of proteins across the blood-brain barrier.

Authors:  Brian J Spencer; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

Review 6.  Recent advances in lentiviral vector development and applications.

Authors:  Janka Mátrai; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

7.  In vivo fluorescence imaging is well-suited for the monitoring of adenovirus directed transgene expression in living organisms.

Authors:  Sevim Kahraman; Ercument Dirice; Ahter Dilsad Sanlioglu; Burcak Yoldas; Huseyin Bagci; Metin Erkilic; Thomas S Griffith; Salih Sanlioglu
Journal:  Mol Imaging Biol       Date:  2009-09-30       Impact factor: 3.488

8.  Non-invasive detection of a small number of bioluminescent cancer cells in vivo.

Authors:  Jae-Beom Kim; Konnie Urban; Edward Cochran; Steve Lee; Angel Ang; Bradley Rice; Adam Bata; Kenneth Campbell; Richard Coffee; Alex Gorodinsky; Zhan Lu; He Zhou; Takashi Kei Kishimoto; Peter Lassota
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

9.  Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.

Authors:  Lei Deng; Guoqiang Li; Lisen Xi; Aihong Yin; Yun Gao; Wei You; Xuehao Wang; Beicheng Sun
Journal:  BMC Gastroenterol       Date:  2009-10-06       Impact factor: 3.067

10.  Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain.

Authors:  David M Markusic; Niek P van Til; Johan K Hiralall; Ronald P J Oude Elferink; Jurgen Seppen
Journal:  BMC Biotechnol       Date:  2009-10-07       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.